商铺首页
公司详情
产品陈列室
公司证书
联系方式
基本信息
企业名称
武汉瑞晟药业有限公司
企业地址
湖北省鄂州市葛店经济技术开发区创业大道28号
成立日期
2009
企业规模(人)
150至199
年销售额(USD)
不愿意公开
企业简介
武汉启瑞科技发展有限公司是一家从事生物工程和新药研发、仿制药生产、销售的高科技民营企业。旗下拥有五个成员公司,包括两个研发中心、两个生产基地和一个营销中心。基地主要分布在武汉、上海和鄂州,营销网络覆盖全国各省、市、自治区。武汉中有药业有限公司正是旗下一家符合CGMP的现代化仿制药研发、原料药及高级中间体生产基地。
主要竞争优势
经验丰富的研发人员,生产能力,合同定制
邮政编码
436070
里程碑
2013年,获得CFDA阿托伐他汀钙原料药GMP、甲磺酸法舒地尔原料药GMP 2016年,获得CFDA索法酮原料药GMP
贸易信息
业务类型
制造商
主要销售市场
北美洲,西欧,东欧,亚洲
主营产品类别
合同外包、定制服务及咨询,药用辅料,中间体,原料药
合同定制与外包服务
CMO
参展信息
主营产品
L-aspartate L-ornithine(3230-94-2);Ademetionine 1,4-Butanedisulfonate(101020-79-5);Azilsartan Medoxomil Potassium(863031-24-7);Azilsartan(147403-03-0);Posaconazole (171228-49-2);Voriconazole(137234-62-9);Tigecycline(220620-09-7);Isavuconazonium sulfate(946075-13-4);Betadex Sulfobutyl Ether Sodium(182410-00-0);(2R,3S/2S,3R)-3-(4-Chloro-5-fluoro-6-pyrimidinyl)-2-(2,4-difluorophenyl)butan-2-ol hydrochloride(188416-35-5,188416-20-8);2-[(1S,2S)-1-Ethyl-2-benzyloxypropyl]-2,4-dihydro-4-[4-[4-(4-hydroxyphenyl)-1-piperazinyl]phenyl]-3H-1,2,4-triazol-3-one(184177-83-1 );(5R-cis)-Toluene-4-sulfonic acid 5-(2,4-difluorophenyl)-5-(1H-1,2,4-triazol-1-yl)methyltetrahydrofuran-3-ylmethyl ester(149809-43-8);2-[2-(2,4-difluorophenyl)-2-propen-1-yl]-1,3-propan(165115-73-1);Phenyl (4-(4-(4-hydroxyphenyl)piperazin-1-yl)phenyl)carbamate(184177-81-9);N'-((2S,3S)-2-(Benzyloxy)pentan-3-yl)formohydrazide oxalate(1887197-42-3);Methyl 2,3-diaminobenzoate(107582-20-7);methyl 1-[(2'-cyanobiphenyl-4-yl)methyl]-2-ethoxy-benzimidazole-7-carboxylate(139481-44-0);(Z)-Methyl 2-ethoxy-3-((2'-(N'-hydroxycarbaMiMidoyl)biphenyl-4-yl)Methyl)-3H-benzo[d] iMidazole-4-carboxylate or methyl (Z)-2-ethoxy-1-((2'-(N'-hydroxycarbamimidoyl)-[1,1'-biphenyl]-4-yl)methyl)-1H-benzo[d]imidazole-7-carboxylate(147403-65-4);Methyl 2-ethoxy-1-[[2′-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)biphenyl-4-yl]methyl]-1H-benzimidazole-7-carboxylate or methyl 2-ethoxy-1-((2'-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)-[1,1'-biphenyl]-4-yl)methyl)-1H-benzo[d]imidazole-7-carboxylate(147403-52-9);4-(HydroxyMethyl)-5-Methyl-[1,3]dioxol-2-one(91526-18-0);1,4-Butane-disulfonate(27665-39-0);1,4-Butanedisulfonic acid disodium salt(36589-61-4);3,3-Dimethylallyl bromide(870-63-3);9-aminominocycline disulfate(153621-83-1,149934-20-3,157517-70-9);(R,E)-5-([1,1'-biphenyl]-4-yl)-4-((tert-butoxycarbonyl)amino)-2-methyl-2-pentenoic acid(1012341-48-8);(2R,4S)-5-([1,1'-biphenyl]-4-yl)-4-((tert-butoxycarbonyl)amino)-2-methylpentanoic acid(1012341-50-2);methyl 4-{1-[(benzyloxy)carbonyl]-4-oxo-1,2,3,4-tetrahydropyridin-2-yl}benzoate(2408761-16-8);benzyl 2-(4-(methoxycarbonyl)phenyl)-4-oxopiperidine-1-carboxylate(2238811-87-3);benzyl (2S)-2-(4-methoxycarbonylphenyl)-4-oxo-piperidine-1-carboxylate(2408761-20-4);benzyl 2-(4-cyanophenyl)-4-oxopiperidine-1-carboxylate(1644667-45-7);benzyl (2S,4S)-4-ethoxy-2-(4-(methoxycarbonyl)phenyl)piperidine-1-carboxylate(1644667-60-6);2-Methyl-2-propanyl 4-formyl-5-methoxy-7-methyl-1H-indole-1-carboxylate(1481631-51-9);3,5-Difluorobenzene-1-sulfonyl chloride(210532-25-5);2-Amino-4-chloropyridine(19798-80-2);2-Methyl-2-propanyl (2S)-2-ethynyl-4-morpholinecarboxylate(1621165-19-2);5-Bromo-4-fluoro-2-nitrobenzaldehyde(213382-45-7);6-Methyl-2-pyridinecarboxylic acid(934-60-1);trans-4-(Dibenzylamino)-1-methylcyclohexanol(177908-36-0);4-(5-bromo-6-methylpyridin-2-yl)-1-methyl-1H-1,2,3-triazol-5-amine;(4-(5-bromo-6-methylpyridin-2-yl)-1-methyl-1H-1,2,3-triazol-5-yl)methanol(2170130-12-6);(R)-3,3-difluoropentan-2-ol;2-(1-((tert-butyldimethylsilanyl)ethynyl)cyclopropyl)ethanoic acid methyl ester(3074985-25-1);1-(6-fluoro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)Indolin-1-yl)ethan-1-one(2922459-48-9);4-bromo-3-nitro-1-(tetrahydro-2H-pyran-2-yl)-1H-pyrazole(1235407-33-6);2-hydroxymethyl-3,5,6-trimethylpyrazine(75907-74-3);tert-butyl (R)-(6,7-dihydro-5H-cyclopenta[b]pyridin-5-yl)carbamate;2-chloropyrimidine-5-carboxylic acid(374068-01-6);8-Oxa-2-azaspiro[4.5]decane hydrochloride(1:1) (1408074-48-5,310-93-0);6-Azaspiro[2.5]octane hydrochloride(1:1) (1037834-62-0);1-Bromo-3-(bromomethyl)-5-iodobenzene (1261553-05-2);Ethyl nicotinate(614-18-6);S-Adenosyl-L-methionine Disulfate Tosylate(97540-22-2);Sodium hyaluronate(9067-32-7);Urolithin A(1143-70-0);Spermidine(124-20-9);Pterostilbene(537-42-8);Phosphatidylserine(51446-62-9);Calcifediol(19356-17-3);Curcumin(458-37-7);Allicin(539-86-6);Sclareol(515-03-7);(-)Ambrox(6790-58-5);DL-Limonene(138-86-3);Rose oxide(16409-43-1);Floral pyranol(63500-71-0);Farnesol(4602-84-0);alpha-isomethyl ionone(127-51-5);Astaxanthin(472-61-7);Lycopene(502-65-8);Xanthophyll(127-40-2)
参展展会
第二十三届世界制药原料中国展
展会时间
2025-03-06至2025-07-31
展位号
E7C22
展品分类
Active Pharmaceutical Ingredients;Intermediates & Fine Chemicals;Excipients & Drug Formulation;Natural Extracts;Finished Dosage;CMO & CRO
参展信息
×